A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia)

References

• CvitanovicSZnaorLKanceljak-MacanBMacanJGudeljIGrbicDAllergic rhinitis and asthma in Southern Croatia: impact of sensitisation to Ambrosia elatiorCroat Med J2007481687517309141
   PubMed Web of Science ®Google Scholar
• BarnesCPachecoFLanduytJHuFPortnoyJHourly variation of airborne ragweed pollen in Kansas CityAnn Allergy Asthma Immunol200186216617111258685
   PubMed Web of Science ®Google Scholar
• TaramarcazPMoetteliLEigenmannPPrevalence of ragweed allergy in rural Geneva – a pilot studySwiss Med Wkly2015145w1419826496716
   PubMed Web of Science ®Google Scholar
• BurbachGJHeinzerlingLMRöhneltCBergmannKCBehrendtHZuberbierTRagweed sensitization in Europe – GA2LEN study suggests increasing prevalenceAllergy200964466466519210367
   PubMed Web of Science ®Google Scholar
• MezeiGJarai-KomoldiMMedzihradskyZCserhatiESeasonal allergenic rhinitis and pollen count (a 5-year survey in Budapest)Orv Hetil19951362172117247651707
   PubMedGoogle Scholar
• de WegerLAPashleyCHŠikoparijaBThe long distance transport of airborne Ambrosia pollen to the UK and the Netherlands from Central and south EuropeInt J Biometeorol Epub2016427
   Web of Science ®Google Scholar
• Della TorreFSalaSSciancaleporeLCassaniLPiazzaGRagweed and allergy: epidemiologyAllergy199651123
   Web of Science ®Google Scholar
• PeternelRMusic MilanovicSSrnecLAirborne ragweed (Ambrosia artemisiifolia L.) pollen content in the city of Zagreb and implications on pollen allergyAnn Agric Environ Med200815112513018581990
   PubMed Web of Science ®Google Scholar
• LaaidiMLaaidiKBesancenotJThibaudonMRagweed in France: an invasive plant and its allergenic pollenAnn Allergy Asthma Immunol200391219520112952115
   PubMed Web of Science ®Google Scholar
• TossiAWütrichBBoniniMPietragalla-KöhlerBTime lag between Ambrosia sensitisation and Ambrosia allergy: a 20-year study (1989–2008) in Legnano, northern ItalySwiss Med Wkly2011141w1325321984071
   PubMed Web of Science ®Google Scholar
• JägerSRagweed (Ambrosia) sensitisation rates correlate with the amount of inhaled airborne pollen. A 14-year study in Vienna, AustriaAerobiologia200016149153
   Google Scholar
• RybnicekOJägerSAmbrosia (ragweed) in EuropeAllergy Clin Immunol Int2001136066
   Google Scholar
• TaramarcazPLambeletBClotBKeimerCHauserCRagweed (Ambrosia) progression and its health risks: will Switzerland resist this invasion?Swiss Med Wkly200513537–3853854816333764
   PubMed Web of Science ®Google Scholar
• CaillaudDThibaudonMMartinSShort-term effects of airborne ragweed pollen on clinical symptoms of hay fever in a panel of 30 patientsJ Investig Allergol Clin Immunol2014244249256
   Web of Science ®Google Scholar
• RobertsGXatzipsaltiMBorregoLMPaediatric rhinitis: position paper of the European Academy of Allergy and Clinical ImmunologyAllergy20136891102111623952296
   PubMed Web of Science ®Google Scholar
• SantosABorregoLRotirotiGScaddingGRobertsGThe need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practiceClin Transl Allergy201551225657844
   PubMed Web of Science ®Google Scholar
• PfaarOBachertCBufeAGuideline on allergen-specific immunotherapy in IgE-mediated allergic diseasesAllergo J Int201423828231926120539
   PubMedGoogle Scholar
• EngPABorer-ReinholdMHeijnenIAGnehmHPTwelve-year follow-up after discontinuation of pre-seasonal grass pollen immunotherapy in childhoodAllergy200661219820116409196
   PubMed Web of Science ®Google Scholar
• JacobsenLNiggemannBDreborgSSpecific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT studyAllergy200762894394817620073
   PubMed Web of Science ®Google Scholar
• SpeharMDodigSHrgaISimicDTurkaljMVenusMConcentration of IgE in children during ragweed pollination seasonAerobiologia (Bologna)201012934
   Web of Science ®Google Scholar
• LiJTLockeyRFBernsteinIPortnoyJMNicklasRAAllergen immunotherapy: a practice parameterAnn Allergy Asthma Immunol200390suppl 1140
   Web of Science ®Google Scholar
• EMEA/CHMP/BWP, European Medicines Agency, Committee for Medicinal Products for Human UseGuideline on Allergen Products: Production and Quality IssuesLondonEuropean Medicines Agency; Committee for medicinal products for Human Use2008 EMEA/CHMP/BWP/304831/2007
   Google Scholar
• van ReeRChapmanMDFerreiraFThe CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantificationAllergy200863331032618269676
   PubMed Web of Science ®Google Scholar
• BurksAWCalderonMACasaleTUpdate on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus reportJ Allergy Clin Immunol201313151288.7e31296.7e323498595
   PubMed Web of Science ®Google Scholar
• El KelishAZhaoFHellerWRagweed (Ambrosia artemisiifolia) pollen allergenicity: superSAGE transcriptomic analysis upon elevated CO2 and drought stressBMC Plant Biol20141417624972689
   PubMed Web of Science ®Google Scholar
• BagnascoMAltrinettiVPesceGPharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteersInt Arch Allergy Immunol2005138319720216205097
   PubMed Web of Science ®Google Scholar
• AllamJWürtzenPReinartzMPhl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing propertiesJ Allergy Clin Immunol20101263638.e1645.e120584546
   PubMed Web of Science ®Google Scholar
• AkdisMAkdisCAMechanisms of allergen-specific immunotherapyJ Allergy Clin Immunol2007119478079117321578
   PubMed Web of Science ®Google Scholar
• Nouri-AriaKTWachholzPAFrancisJNGrass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activityJ Immunol200417253252325914978133
   PubMed Web of Science ®Google Scholar
• AkdisCAAkdisMMechanisms of immune tolerance to allergens: role of IL-10 and TregsJ Clin Invest2014124114678468025365074
   PubMed Web of Science ®Google Scholar
• TakharPSmurthwaiteLCokerHAAllergen drives class switching to IgE in the nasal mucosa in allergic rhinitisJ Immunol200517485024503215814733
   PubMed Web of Science ®Google Scholar
• ReisingerJHorakFPauliGAllergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivityJ Allergy Clin Immunol2005116234735416083789
   PubMed Web of Science ®Google Scholar
• AkdisMVerhagenJTaylorAImmune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cellsJ Exp Med2004199111567157515173208
   PubMed Web of Science ®Google Scholar
• LundbergKRydnertFBroosSAnderssonMGreiffLLindstedtMAllergen-specific immunotherapy alters the frequency, as well as the FcR and CLR expression profiles of human dendritic cell subsetsPLoS One2016112e014883826863539
   PubMed Web of Science ®Google Scholar
• PfaarOKleine-TebbeJHörmannKKlimekLAllergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials?Immunol Allergy Clin North Am201131228930921530821
   PubMed Web of Science ®Google Scholar
• DemolyPCalderonMADosing and efficacy in specific immunotherapyAllergy201166suppl s95384021668851
   PubMed Web of Science ®Google Scholar
• CalderonMAEichelAMakatsoriMPfaarOComparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trialsCurr Opin Allergy Clin Immunol201212324925622499145
   PubMed Web of Science ®Google Scholar
• EMA/CHMPGuideline on the Clinical Development of Products for Specific Immunotherapy for the Treatment of Allergic DiseasesLondonEuropean Medicines Agency Committee for Medicinal Products for Human Use2008 CHMP/EWP/18504/2006
   Google Scholar
• PfaarODemolyPGerth van WijkRRecommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperAllergy201469785486724761804
   PubMed Web of Science ®Google Scholar
• BousquetPJBrozekJBachertCThe CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paperAllergy200964121737174519860788
   PubMed Web of Science ®Google Scholar
• CanonicaGWBaena-CagnaniCEBousquetJRecommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforceAllergy200762331732417298350
   PubMed Web of Science ®Google Scholar
• CarrWBernsteinJLiebermanPA novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitisJ Allergy Clin Immunol201212951282128922418065
   PubMed Web of Science ®Google Scholar
• MatricardiPMKunaPPanettaVWahnUNarkusASubcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analysesJ Allergy Clin Immunol2011128479179921620452
   PubMed Web of Science ®Google Scholar
• ValleCBazziSBerraDSillanoVPuccinelliPParmianiSEffects of sublingual immunotherapy in patients sensitised to Ambrosia. An open controlled studyAllergol et Immunopathol2000286311317
   Google Scholar
• DretzkeJMeadowsANovielliNHuissoonAFry-SmithAMeadsCSubcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparisonJ Allergy Clin Immunol201313151361136623557834
   PubMed Web of Science ®Google Scholar
• RadulovicSCalderonMAWilsonDDurhamSSublingual immunotherapy for allergic rhinitisCochrane Database Syst Rev2010812CD002893
   Google Scholar
• PenagosMCompalatiETarantiniFEfficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trialsAnn Allergy Asthma Immunol200697214114816937742
   PubMed Web of Science ®Google Scholar
• MarognaMTomassettiDBernasconiAPreventive effects of sublingual immunotherapy in childhood: an open randomized controlled studyAnn Allergy Asthma Immunol2008101220621118727478
   PubMed Web of Science ®Google Scholar
• CoxLSublingual immunotherapy and allergic rhinitisCurr Allergy Asthma Rep20088210211018417051
   PubMed Web of Science ®Google Scholar
• AasbjergKBackerVLundGImmunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergyClin Exp Allergy201444341742824734285
   PubMed Web of Science ®Google Scholar
• GINA [homepage on the Internet]Global Strategy for Asthma Management and Prevention: Global Initiative for Asthma2006 Available from: www.ginasthma.orgAccessed May 14, 2013
   Google Scholar
• AbramsonMJPuyRMWeinerJMInjection allergen immunotherapy for asthmaCochrane Database Syst Rev201048CD001186
   Google Scholar
• MauroMRusselloMIncorvaiaCBirch-apple syndrome treated with birch pollen immunotherapyInt Arch Allergy Immunol2011156441642221832831
   PubMed Web of Science ®Google Scholar
• BaeJMChoiYYParkCOChungKYLeeKHEfficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trialsJ Allergy Clin Immunol2013132111011723647790
   PubMed Web of Science ®Google Scholar
• CalderonMAFranklandWADemolyPAllergen immunotherapy and allergic rhinitis: false beliefsBMC Med20131125524314210
   PubMed Web of Science ®Google Scholar
• MigueresMDavilaIFratiFTypes of sensitisation to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory diseaseClin Transl Allergy201441624817997
   PubMed Web of Science ®Google Scholar
• DurhamSRBirkAOAndersenJSDays with severe symptoms: an additional efficacy endpoint in immunotherapy trialsAllergy201166112012320608918
   PubMed Web of Science ®Google Scholar
• CoxLCalderonMPfaarOSubcutaneous allergen immunotherapy, safety and cost-effectiveness of current and novel formulationsImmunotherapy20124660161622788128
   PubMed Web of Science ®Google Scholar
• MallingHJMinimising the risks of allergen-specific injection immunotherapyDrug Saf200023432333211051219
   PubMed Web of Science ®Google Scholar
• KelsoJMThe rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reactionAnn Allergy Asthma Immunol200492222522714989390
   PubMed Web of Science ®Google Scholar
• VogelbruchMNussBKörnerMKappAKiehlPBohmWAluminium-induced granulomas after inaccurate intradermal hyposensitisation injections of aluminium-adsorbed depot preparationsAllergy200055988388711003454
   PubMed Web of Science ®Google Scholar
• NetterlidEHindsénMBjörkJThere is an association between contact allergy to aluminium and persistent subcutaneous nodules in children undergoing hyposensitisation therapyContact Dermatitis2009601414919125720
   PubMed Web of Science ®Google Scholar
• FrostLJohansenPPedersenSVeienNOstergaardPANielsenMHPersistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extractsAllergy19854053683724037257
   PubMed Web of Science ®Google Scholar
• LopezSPelaezANavarroLAMontesinosEMoralesCCardaCAluminium allergy in patients hyposensitized with aluminium-precipitated antigen extractsContact Dermatitis199431137407924292
   PubMed Web of Science ®Google Scholar
• CoxLLarenas-LinnemannDLockeyRFPassalacquaGSpeaking the same language: the World Allergy Organization subcutaneous immunotherapy systemic reaction grading systemJ Allergy Clin Immunol2010125356957420144472
   PubMed Web of Science ®Google Scholar
• PassalacquaGBaena-CagnaniCEBousquetJGrading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same languageJ Allergy Clin Immunol20131321939823683513
   PubMed Web of Science ®Google Scholar
• RagusaFVPassalacquaGGambardellaRNonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experienceJ Investig Allergol Clin Immunol199773151154
   PubMed Web of Science ®Google Scholar
• BernsteinDIWannerMBorishLLissGMImmunotherapy Committee, American Academy of Allergy, Asthma and ImmunologyTwelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001J Allergy Clin Immunol200411361129113615208595
   PubMed Web of Science ®Google Scholar
• CaminatiMDamaARDjuricIIncidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safetyExpert Rev Clin Immunol201511223324525484197
   PubMed Web of Science ®Google Scholar
• MakatsoriMCalderonMAAnaphylaxis: still a ghost behind allergen immuno therapyCurr Opin Allergy Clin Immunol201414431632224873937
   PubMed Web of Science ®Google Scholar
• Lüderitz-PüchelUKeller-StanislawskiBHausteinDRisk reevaluation of diagnostic and therapeutic allergen extracts. An analysis of adverse drug reactions from 1991 to 2000Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz200144709718
   Google Scholar
• Alvarez-CuestaEBousquetJCanonicaGWStandards for practical allergen-specific immunotherapyAllergy200682suppl120
   Web of Science ®Google Scholar
• NielsenLJohnsenCRMosbechHPoulsenLKMallingHJAntihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled studyJ Allergy Clin Immunol1996976120712138648014
   PubMed Web of Science ®Google Scholar
• LiJTBernsteinDICalderonMASublingual grass and ragweed immunotherapy: clinical considerations-a PRACTALL consensus reportJ Allergy Clin Immunol2016137236937626371843
   PubMed Web of Science ®Google Scholar
• CalderónMASimonsFEMallingHJLockeyRFMoingeonPDemolyPSublingual allergen immunotherapy: mode of action and its relationship with the safety profileAllergy201267330231122150126
   PubMed Web of Science ®Google Scholar
• CoxLSLarenas-LinnemannDNolteHWeldonDFinegoldINelsonHSSublingual immunotherapy: a comprehensive reviewJ Allergy Clin Immunol200611751021103516675328
   PubMed Web of Science ®Google Scholar
• PassalacquaGGarelliVSclifòFCanonicaGWSublingual immunotherapy for allergic rhinitis and conjunctivitisImmunotherapy20135325726423444955
   PubMed Web of Science ®Google Scholar
• CanonicaGWCoxLPawankarRSublingual immunotherapy: World Allergy Organization position paper 2013 updateWorld Allergy Organ J201471624679069
   PubMedGoogle Scholar
• FiocchiAPajnoGLa GruttaSSafety of sublingual-swallow immunotherapy in children aged 3 to 7 yearsAnn Allergy Asthma Immunol200595325425816200816
   PubMed Web of Science ®Google Scholar
• BaiardiniIBraidoFBoniniMCompalatiECanonicaGWWhy do doctors and patients not follow guidelines?Curr Opin Allergy Clin Immunol20099322823319390434
   PubMed Web of Science ®Google Scholar
• SondermannNShah-HosseiniKHenkelKSchwalfenbergAMösgesRFactors of success for adherence in hyposensitisationAllergologie201134441446
   Web of Science ®Google Scholar
• ClaesCMittendorfTGraf von der SchulenburgJMPersistence and frequency of prescriptions of subcutaneous allergen-specific immunotherapy (SCIT) prescribed within the German statutory health insuranceMed Klin20091047536542
   Google Scholar
• EberlePSchrederHShah-HosseiniKMösgesRMedication persistence in children and young people on long-term grass pollen specific immunotherapy – measured by prescription renewal ratesAllergologie201336918
   Web of Science ®Google Scholar
• KielMARöderEGerth van WijkRAlMJHopWCRutten-van MölkenMPReal-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapyJ Allergy Clin Immunol2013132235336223651609
   PubMed Web of Science ®Google Scholar
• ReeveLBaldrickPHewingsSSkinnerMA battery of genotoxicity studies with an allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergyJ Appl Toxicol201232860861621919021
   PubMed Web of Science ®Google Scholar
• PfaarOCazanDKlimekLLarenas-LinnemannDCalderonMAAdjuvants for immunotherapyCurr Opin Allergy Clin Immunol201212664865723090384
   PubMed Web of Science ®Google Scholar
• JutelMSolarewicz-MadejekKSmolinskaSRecombinant allergens: the present and the futureHum Vaccin Immunother20128101534154323095874
   PubMed Web of Science ®Google Scholar
• JohansenPvon MoosSMohananDKündigTMSentiGNew routes for allergen immunotherapyHum Vaccin Immunother20128101525153323095873
   PubMed Web of Science ®Google Scholar
• Larenas-LinnemannDWahnUKoppMUse of omalizumab to improve desensitisation safety in allergen immunotherapyJ Allergy Clin Immunol20141333937.e224581432
   PubMed Web of Science ®Google Scholar
• European Aeroallergen Network [webpage on the Internet]Polleninfo.org Available from: https://www.polleninfo.org/GB/en/current-data.html?poll=6&month=9&tabber=6&time=1Accessed May 1, 2016
   Google Scholar
• LockeyRFLedfordDKAllergens and Allergen Immunotherapy: Subcutaneous, Sublingual and Oral5th edBoca Raton, FLCRC Press, Taylor & Francis Group2014
   Google Scholar
• KimHWasermanSHébertJEfficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitisAllergy Asthma Clin Immunol20141015525788949
   PubMed Web of Science ®Google Scholar
• CreticosPSMaloneyJBernsteinDIRandomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adultsJ Allergy Clin Immunol201313151342.e61349.e623622121
   PubMed Web of Science ®Google Scholar
• NolteHHébertJBermanGRandomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adultsAnn Allergy Asthma Immunol20131106450.e4456.e423706715
   PubMed Web of Science ®Google Scholar